2449. Validation of In Vitro Activity of Aminoglycosides Against Recently Isolated Helicobacter pylori for Commercialization of Gentamicin-Intercalated Smectite Hybrid as a New Therapeutic Agent

BACKGROUND: The eradication rate of Helicobacter pylori as a standard therapy based on amoxicillin and clarithromycin, exhibits a decreasing trend. Alternative approaches have been explored, but there is still controversy in the regimen change and these do not provide a satisfactory substitute to th...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Kyoung Hwa, Park, Soon Young, Yoo, Seul Gi, Kwon, Da Eun, Jeong, Su Jin, Jung, Da Hyun, Kim, Jie-Hyun, Jeong, Seok Hoon, Kang, Il-Mo, Song, Young Goo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254595/
http://dx.doi.org/10.1093/ofid/ofy210.2102

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254595/
http://dx.doi.org/10.1093/ofid/ofy210.2102

Ejemplares similares